Concepedia

Publication | Open Access

Novel complement inhibitor limits severity of experimentally myasthenia gravis

DOIFull Paper Access

92

Citations

33

References

2009

Year

Jindřich Šoltýs, Linda L. Kusner, Andrew Young, Chelliah Richmonds, Denise A. Hatala, Bendi Gong, Vaithesh Shanmugavel, Henry J. Kaminski
Annals of Neurology

Abstract

Inhibition of complement significantly reduced weakness in two models of EAMG. C5 inhibition could prove to be of significant therapeutic value in human myasthenia gravis.

References

YearCitations

Page 1